(EMAILWIRE.COM, January 16, 2019 ) The global Cell Lysis/Cell Fractionation Market is broadly classified into product, type of cell, end-users, and regions.

Cell Lysis/Cell Fractionation Market On the basis of product;

the cell lysis market is segmented into consumables and instruments. The consumables segment is expected to account for the largest share of the global market in 2016. Consumables include reagents and kits, beads, and disposables. Reagents and kits are further classified into enzymes, detergent solutions, and other reagents and kits. Enzymes are mostly used for chemical cell disruption and form major portion of the reagents and kits market.

Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=260138321

Geographical Analysis;

The Cell Fractionation market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by increasing aging population, and rising government funding in the North American countries.

The major players in the cell lysis market;

Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), QIAGEN N.V. (Netherlands), Qsonica, LLC. (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

Download PDF: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321